Who
W. Bradford Smith
Director
Company insider
Files Form 4 as: Director, Lyra Therapeutics; CFO & Treasurer, Leverage Shares 2X Long FIX Daily ETF; CFO and Treasurer, Ocular Therapeutix; Chief Financial Officer, NeuroMetrix.
In numbers
- Trades disclosed
- 88
- Buys
- 0
- Sells
- 21
- Bought
- $0
- Sold
- $2.9M
- Companies
- 4
- Companies where not an officer
- 1
- First trade
- 4 Jan 2006
- Last trade
- 14 May 2026
- Last filed
- 15 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 May 2026filed 15 May 2026 | Lyra TherapeuticsMedical Devices | SEC FORM 4 Code D | —640 at $0.00 | filing |
| 14 May 2026filed 15 May 2026 | Lyra Therapeutics | SEC FORM 4 Code D | —640 at $0.00 | filing |
| 14 May 2025filed 16 May 2025 | Lyra Therapeuticsoption or derivative | SEC FORM 4 Code A | —32,000 at $0.00 | filing |
| 13 Jun 2024filed 14 Jun 2024 | Lyra Therapeuticsoption or derivative | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 30 Jun 2023filed 5 Jul 2023 | Lyra Therapeuticsoption or derivative | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 23 Feb 2023filed 27 Feb 2023 | FIXX Leverage Shares 2X Long FIX Daily ETFoption or derivative | SEC FORM 4 Code A | —213,000 at $0.00 | filing |
| 23 Feb 2023filed 27 Feb 2023 | FIXX Leverage Shares 2X Long FIX Daily ETFoption or derivative | SEC FORM 4 Code A | —36,000 at $0.00 | filing |
| 9 Jan 2023filed 11 Jan 2023 | FIXX Leverage Shares 2X Long FIX Daily ETF | SEC FORM 4 Sold | $5,1833,729 at $1.39 | filing |
| 1 Jan 2023filed 4 Jan 2023 | FIXX Leverage Shares 2X Long FIX Daily ETFoption or derivative | SEC FORM 4 Code M | —6,600 at $0.00 | filing |
| 1 Jan 2023filed 4 Jan 2023 | FIXX Leverage Shares 2X Long FIX Daily ETFoption or derivative | SEC FORM 4 Code M | —6,930 at $0.00 | filing |
| 1 Jan 2023filed 4 Jan 2023 | FIXX Leverage Shares 2X Long FIX Daily ETF | SEC FORM 4 Code M | —6,600 | filing |
| 1 Jan 2023filed 4 Jan 2023 | FIXX Leverage Shares 2X Long FIX Daily ETF | SEC FORM 4 Code M | —6,930 | filing |
| 16 Jun 2022filed 21 Jun 2022 | Lyra Therapeuticsoption or derivative | SEC FORM 4 Code A | —7,250 at $0.00 | filing |
| 24 Feb 2022filed 28 Feb 2022 | FIXX Leverage Shares 2X Long FIX Daily ETFoption or derivative | SEC FORM 4 Code A | —126,000 at $0.00 | filing |
| 24 Feb 2022filed 28 Feb 2022 | FIXX Leverage Shares 2X Long FIX Daily ETFoption or derivative | SEC FORM 4 Code A | —21,000 at $0.00 | filing |
| 5 Jan 2022filed 12 Jan 2022 | FIXX Leverage Shares 2X Long FIX Daily ETF | SEC FORM 4 Sold | $8,2482,182 at $3.78 | filing |
| 1 Jan 2022filed 12 Jan 2022 | FIXX Leverage Shares 2X Long FIX Daily ETFoption or derivative | SEC FORM 4 Code M | —6,600 at $0.00 | filing |
| 1 Jan 2022filed 12 Jan 2022 | FIXX Leverage Shares 2X Long FIX Daily ETF | SEC FORM 4 Code M | —6,600 | filing |
| 26 May 2021filed 28 May 2021 | Lyra Therapeuticsoption or derivative | SEC FORM 4 Code A | —7,250 at $0.00 | filing |
| 8 Feb 2021filed 9 Feb 2021 | FIXX Leverage Shares 2X Long FIX Daily ETFoption or derivative | SEC FORM 4 Code M | —13,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.